Clinical Trials Sponsored by Shenzhen NewDEL Biotech, Co., Ltd

Total 816 results

Guangdong Raynovent Biotech Co., Ltd

Completed

Bioavailability Study in Healthy Participants, 200mg Tablets ZSP1273 Versus 200mg Granules ZSP1273

Bioequivalence

China
Shanghai HyaMab Biotech Co.,Ltd.

Completed

PE0116 Injection in Treatment of Patients With Advanced Solid Tumours

Locally Advanced/Metastatic Solid Tumors

China
Guangdong Raynovent Biotech Co., Ltd

Completed

Pharmacokinetics of Leritrelvir(RAY1216) in Participants With Hepatic Impairment

Hepatic Impairment

China
Guangdong Raynovent Biotech Co., Ltd

Completed

Pharmacokinetics of ZSP1273 in Participants With Hepatic Impairment

Pharmacokinetics | Hepatic Impairment

China
Guangdong Raynovent Biotech Co., Ltd

Completed

A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A

Influenza A

China
Qingdao HIGHTOP Biotech Co., Ltd.

Completed

Neutrophil Gelatinase-Associated Lipocalin (NGAL) Rapid Test (Colloidal Gold) Clinical Trial Protocol

Peritoneal Dialysis-associated Peritonitis

China
Beijing Northland Biotech. Co., Ltd.

Completed

Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.Infarction

Acute Myocardial Infarction

China
Chengdu Kanghong Biotech Co., Ltd.

Terminated

Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-1)

Neovascular Age-related Macular Degeneration

United States, Argentina, Australia, Austria, Belgium, Canada, Chile, Colombia, Germany, Hong Kong, Lithuania, Mexico, Netherlands, New Zealand, Peru, Philippines, Poland, Portugal, Singapore, Spain, Switzerland, Taiwan
Chengdu Kanghong Biotech Co., Ltd.

Terminated

Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-2)

Neovascular Age-related Macular Degeneration

United States, Bulgaria, China, Czechia, Denmark, France, Hungary, Israel, Italy, Latvia, Slovakia, United Kingdom
Beijing Mabworks Biotech Co., Ltd.

Completed

A Study of MIL62 in Treatment of CD20 Positive B-cell Lymphomas

CD20-positive B Cell Non-Hodgkin Lymphoma

China
Beijing Northland Biotech. Co., Ltd.

Completed

A Phase 1a Study of Thymosin Beta 4 in Healthy Volunteers

Healthy

China
Beijing Northland Biotech. Co., Ltd.

Completed

A Phase 1b Study of Thymosin Beta 4 in Healthy Volunteers

Healthy

China
Guangdong Raynovent Biotech Co., Ltd

Completed

Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A

Influenza A

China
Angde Biotech Pharmaceutical Co., Ltd.

Unknown

Injection of Recombinant Human Tissue-type Plasminogen Activator Derivative for Acute Pulmonary Embolism(rPA) (rPA)

Acute Pulmonary Embolism
Guangzhou Wondfo Biotech Co., Ltd

Suspended

Preview Rapid Strep A Test Method Comparison Study

Strep Throat

United States
Yinyi(Liaoning) Biotech Co., Ltd.

Completed

Bingo Drug-eluting Balloon in Bifurcation

Bifurcation Lesions | Drug Eluting Balloon

China
Chengdu Kanghong Biotech Co., Ltd.

Unknown

The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV) (STAR)

Polypoidal Choroidal Vasculopathy (PCV)

China
Angde Biotech Pharmaceutical Co., Ltd.

Unknown

A Study of the Recombinant Human Interleukin-11 (I) (Baijieyi) for Prevention and Treatment of Chemotherapy-induced Thrombocytopenia in Patients With Malignant Tumor

Chemotherapy-induced Thrombocytopenia

China
Chengdu Kanghong Biotech Co., Ltd.

Unknown

Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)

Diabetic Macular Edema

China
Xiamen Amoytop Biotech Co., Ltd.

Completed

PK & PD Study of Pegylated rhEPO, and Evaluated Its Safety and Tolerability in Male Healthy Individual

Healthy

China
Chengdu Kanghong Biotech Co., Ltd.

Unknown

Efficacy and Safety of Conbercept in Macular Edema Secondary to Retinal Vein Occlusion (FALCON)

Retinal Vein Occlusion

China
Xiamen Amoytop Biotech Co., Ltd.

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Assessment of Ypeginterferon Alfa-2a in Healthy Subjects

Healthy Subjects

China
Shenzhen Core Medical Technology CO.,LTD.

Recruiting

CorVad Percutaneous Ventricular Assist System Study

Coronary Artery Disease

China
Shenzhen Yangli Pharmaceutical Technology Co., Ltd

Recruiting

Study of TFX06 in Women With Advanced Breast Cancer.

Metastatic Breast Cancer | ER+, HER2- Advanced Breast Cancer

China
Shenzhen Yangli Pharmaceutical Technology Co., Ltd

Recruiting

A Study of TFX05-01 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Shenzhen Core Medical Technology CO.,LTD.

Completed

Corheart 6 LVAS LTFU

End-stage Heart Failure

China
Lifetech Scientific (Shenzhen) Co., Ltd.
Medtronic

Completed

Lifetech CeraFlex™ Post-Market Surveillance Study

Atrial Septal Defect | Patent Foramen Ovale | Patent Ductus Arteriosus

Germany, Switzerland, France, Ireland, Italy
Shenzhen Core Medical Technology CO.,LTD.

Not yet recruiting

Corheart 6 VAS Study

Refractory Heart Failure

Germany
Anda Biopharmaceutical Development (Shenzhen) Co...

Recruiting

Clinical Trial on Personalized Neoantigen Vaccine for Pancreatic Tumor

Pancreatic Tumor

China
Shenzhen Core Medical Technology CO.,LTD.

Completed

Corheart 6 Left Ventricular Assist System Prospective, Multicenter, Single-arm Clinical Evaluation Trial

End-stage Heart Failure

China
ShenZhen KYD Biomedical Technology Co., Ltd.

Completed

SaExten Vena Cava Filter System in Prevention of Pulmonary Embolism

Pulmonary Embolism

China
Shenzhen Pulsecare Medical Technology Co., Ltd.

Active, not recruiting

Clinical Trial of the Pulse Field Ablation System for the Treatment of Paroxysmal Atrial Fibrillation in 11 Centers in China

Paroxysmal Atrial Fibrillation

China
Sinovac Biotech (Colombia) S.A.S.
Sinovac Life Sciences Co., Ltd.

Not yet recruiting

Immunogenicity and Safety Study of One Booster Dose of Trivalent COVID-19 Vaccine (Vero Cell), Inactivated

COVID-19

Colombia
Sinovac Life Sciences Co., Ltd.

Recruiting

SA55 Injection Phase II Study in the Treatment of Mild/Moderate COVID-19 Patients

Infection of Upper Respiratory Tract Caused by 2019-nCoV

China
Sinovac Life Sciences Co., Ltd.

Completed

Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19)

COVID-19

China
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.
Shenzhen Second People's Hospital

Unknown

Targeted T-cell Therapy in Solid Tumors

Malignant Solid Tumor

China
Sinovac Life Sciences Co., Ltd.

Recruiting

SA55 Injection: a Potential Therapy for the Prevention and Treatment of COVID-19

COVID-19

China
Sinovac Life Sciences Co., Ltd.

Recruiting

Safety and Immunogenicity of Tetanus Vaccine, Adsorbed in 18~44 Years Old Population

Tetanus

China
Sinovac Life Sciences Co., Ltd.

Completed

Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents

COVID-19

China
Sinovac Life Sciences Co., Ltd.

Active, not recruiting

Efficacy and Safety of Anti-COVID-19 Antibody SA58 Nasal Spray to Prevent Infection in High-risk Populations

COVID-19

China
Sinovac Life Sciences Co., Ltd.

Completed

Immunogenicity and Safety of a Third Dose of COVID-19 Vaccine(Vero Cell), Inactivated in the Elderly

COVID-19

China
Shenzhen Sciencare Medical Industries Co., Ltd.

Recruiting

Exploring the PK of Different Doses of Naltrexone in Patients With AUD

AUD

China
Shenzhen Beike Bio-Technology Co., Ltd.

Unknown

Stem Cell Therapy Combined Hormone Replacement Therapy in Patients With Premature Ovarian Failure

Premature Ovarian Failure，

China
Sinovac Life Sciences Co., Ltd.

Not yet recruiting

Phase I Clinical Trial of PCV24 in Adults

Pneumococcal Infectious Disease

China
Sinovac Life Sciences Co., Ltd.

Recruiting

SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray in Health People

COVID-19

China
Sinovac Life Sciences Co., Ltd.

Recruiting

Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

Pneumococcal Infections

China
Sinovac Life Sciences Co., Ltd.

Active, not recruiting

Immunogenicity，Safety and Cross - Immune Response With Mutant Strains of a Third Dose of an Inactivated COVID-19 Vaccine

COVID-19

China
Sinovac Life Sciences Co., Ltd.

Completed

Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Children and Adolescents

COVID-19

China
Beijing Mabworks Biotech Co., Ltd.
Betta Pharmaceuticals Co., Ltd.

Completed

mil60 Versus Bevacizumab in Patients With Treatment-naïve Non-squamous Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Sinovac Life Sciences Co., Ltd.

Completed

Safety and Immunogenicity Study of Booster Vaccination in Different Doses of COVID-19 Vaccine (Vero Cell),Inactivated for Prevention of COVID-19

COVID-19

China

Clinical Trials Sponsored by Shenzhen NewDEL Biotech, Co., Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations